Dermatologicals Market - Forecast(2024 - 2030)

Report Code: HCR 1433 Report Format: PDF + Excel

Dermatologicals Market Overview

Dermatologicals Market size is estimated to reach $53.4 billion by 2027. Furthermore, it is poised to grow at a CAGR of 8.5% over the forecast period of 2022-2027. Dermatology is a branch of medicine concerned with the diagnosis, prevention, and treatment of illnesses of the nails, skin, and hair, including pigmentation, acne, wrinkles, and psoriasis. The products are used to treat a variety of skin issues and prevent certain skin problems. Drugs including fluticasone propionate, cyclosporine, cyproheptadine, loratadine, hydroxyzine, methotrexate are widely used to address such problems. In addition, dermatological is used for routine skincare to keep one's skin healthy. However, some dermatological preparations are systemic and are utilized in inpiduals who do not respond to topical medications. Furthermore, all of these products are used to treat dermatitis, acne, and psoriasis, among other skin disorders. A dermatologist is a doctor who specializes in conditions involving the skin, hair, and nails. A dermatologist can identify and treat more than 3,000 conditions. These conditions include eczema, psoriasis, and skin cancer, among many others. Dermatology diseases include common skin rashes to severe skin infections, which occur owing to a range of things, such as infections, heat, allergens, system disorders, and medications. The foremost common skin disorders are dermatitis. Atopic dermatitis is an associated current (chronic) condition that causes restless, inflamed skin. Most frequently it seems as patches on the face, neck, trunk, or limbs. It tends to flare up sporadically so subside for a time. The rising prevalence of skin diseases and the technological advancement in the field of dermatology are some of the factors driving the Dermatological Industry forward in the projected period of 2022-2027. 

Dermatologicals Market Report Coverage

The report: “Dermatologicals Market Forecast (2022-2027)", by Industry ARC covers an in-depth analysis of the following segments of the Dermatologicals Market. 

By Diseases- Acne, Dermatitis, Psoriasis, Skin cancer, Rosacea, Alopecia, and Others.
By Route of Administration- Topical Administration, Oral Administration, and Parenteral Administration.
By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, Chile Colombia and Rest of South America), and Rest of the World (the Middle East, and Africa).

Key Takeaways

  • Geographically, in 2021 North America held a dominant market share. Skin disease is the most common disease in the United States and affects as many as one in three Americans at any given time. Common skin conditions include acne, contact dermatitis, benign tumors, cancers, atopic dermatitis (also called eczema), and psoriasis. Owing to the increasing rate of skin cancer in the U.S., the availability of dermatology products has increased. This factor also increases the production of dermatology products and thus the demand for the dermatological sector surges. Dermatologists care for more skin disease visits than any other single specialty, while still accounting for a minority of visits overall. These visits for skin disease represent a considerable disease burden in the United States. Moreover, an increase in personal protective equipment (PPE) use and hygiene measures such as the use of hand sanitizers, hand washing, and mask usage during this pandemic have increased the frequency of dermatological diseases.
  • The rising prevalence of skin diseases and the technological advancement in the field of dermatology are some of the factors driving the Dermatologicals Market. However, the rising side effects from dermatological products are one of the factors impeding the market growth.
  • A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Dermatologicals Market Report.

Dermatologicals Market- Geography (%) for 2021.

Dermatologicals Market

For more details on this report - Request for Sample

Dermatologicals Market Segmentation Analysis- By Diseases

The Dermatologicals market based on diseases can be further segmented into Acne, Dermatitis, Psoriasis, skin cancer, Rosacea, Alopecia, and Others. Acne held a dominant market share in the year 2021. Acne is a common skin ailment that creates pimples on the face, forehead, chest, shoulders, and upper back, among other places. Genetics, fluctuating hormone levels, stress, high humidity, and the use of oily or greasy personal care products are all possible causes. Acne is most frequent among teenagers, but it can strike anyone at any age. According to the American Academy of Dermatology, around 20% of newborns develop a type of acne called neonatal acne, which usually appears between the second and fourth weeks of life. This type of acne goes away on its own without causing scars. It also does not increase the risk of developing severe acne later in life. In pediatric populations, the prevalence of acne increases with age. Acne occurs mainly during puberty when the sebaceous glands are stimulated by increased hormone levels. Therefore, the rising number of acne further roses the demand for the dermatological sector.

However, Psoriasis is estimated to be the fastest-growing, with a CAGR of 9.9% over the forecast period of 2022-2027. Psoriasis is a skin condition that causes red, itchy scaly patches on the knees, elbows, trunk, and scalp, among other places. Psoriasis is a chronic (long-term) condition that has no cure. It goes through cycles, with flare-ups lasting a few weeks or months, then diminishing or going into remission. Patches are typically found on the elbows, knees, scalp, lower back, face, palms, and soles of feet, but can affect other places (fingernails, toenails, and mouth). The most common type of psoriasis is called plaque psoriasis. The patches can seem pink or red on brown, black, or white skin, and the scales can appear white or silvery. The patches on brown and black skin can appear purple or dark brown, and the scales can appear grey.

Dermatologicals Market Segmentation Analysis- By Route of Administration

The Dermatologicals market based on the Route of Administration can be further segmented into, Topical Administration, Oral Administration, and Parenteral Administration. Topical Administration held a dominant market share in the year 2021. Topical administration such as gels is mostly applied for the treatment of skin diseases as it helps to heal the treatment rapidly and effectively. Topical medications are lotions, creams, and ointments that one applies to the skin to relieve itching, burning, and pain, as well as to reduce swelling and inflammation, or stop infection. Topical medications are medications applied to the surface of the skin for the treatment of a variety of skin conditions. However, more severe skin problems often require the use of prescription topical medication for improvement and control of symptoms. Also, topical treatment is crucial for the successful management of plaque psoriasis. Topicals are used either as a stand-alone therapy for mild psoriasis or else in combination with UV or systemic treatment for moderate-to-severe disease.

However, Parenteral Administration is estimated to be the fastest-growing, with a CAGR of 10.4% over the forecast period of 2022-2027. It is owing to the advancement of technology and the rising number of biological drugs. The current dermatological uses intravenous administration for the treatment of dermatomyositis and autoimmune bullous disorders, epidermolysis bullosa acquisita, pemphigoid, and pemphigus. Increasing use of this therapy has helped to establish its excellent safety record, without the many adverse effects of steroids and other immunosuppressive agents. 

Dermatologicals Market Segmentation Analysis- By Geography

The Dermatologicals market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. In 2021, North America held a dominant market share of 42% as compared to its other counterparts. Skin illness is the most common disease in the United States, affecting up to one-third of the population at any given time. According to the American Academy of Dermatology, about 84.5 million Americans are suffering from skin diseases in 2020 which in turn accelerates the demand for dermatology products and thus surges the market growth. Acne, contact dermatitis, benign tumors, malignancies, atopic dermatitis (also known as eczema), and psoriasis are all common skin diseases. The availability of dermatology products has expanded as the risk of skin cancer in the United States has risen. As a result of this aspect, dermatology product production increases, and demand for the dermatological industry rises. Dermatologists see more patients with skin diseases than any other specialty, although accounting for a small percentage of all visits. In the United States, these visits for skin disease represent a significant disease burden. Moreover, an increase in personal protective equipment (PPE) use and hygiene measures such as the use of hand sanitizers, hand washing, and mask usage during this pandemic have increased the frequency of dermatological diseases.

Dermatologicals Market Drivers

The Rising Prevalence of Skin Diseases Surges the Demand for Dermatology products that has Readily Aided the Market Growth.

Skin diseases are the fourth most common cause of all human diseases, affecting almost one-third of the world’s population according to the World Health Organization. Skin diseases can significantly impact not only a patient's physical appearance but also their social and emotional well-being. Even the smallest skin lesions have been shown to disrupt a person's level of overall wellness. The burden of skin diseases includes their high prevalence and the associated morbidity over time, including severe itching, for instance in the case of atopic dermatitis and urticaria, or disfigurement, such as in leprosy. The high prevalence of skin cancer and associated treatment costs can be an economic threat to some healthcare systems. Acne is another very common inflammatory dermatosis. Skin disease is a common illness in most tropical regions where the pattern of clinical, presentations is dominated by infections. Along with common diseases such as pyodermas and fungal infections, a group of conditions is known collectively as the neglected tropical diseases of the skin. According to the International Foundation of Dermatology, skin disease is estimated to affect more than 900,000,000 persons globally each year. It is therefore unsurprising that it is one of the common disorders seen at the front-line health care level in all regions. 

Technological Advancement in the Field of Dermatology Gives Rise to the Demand for Dermatologicals Market. 

Manufacturers in the dermatological products market are making use of new and advanced technologies like biomarkers, bioinformatics, molecular targeting, and nanotechnology for medicine discovery. In dermatological biologics, the treatment of psoriasis is the largest area of development as 69% of patients are suffering from psoriasis in 2020 according to the World Health Organization, where more than 10 approved biologics are used to treat moderate to severe psoriasis, propelling the market growth. New developments are on rising in the dermatological products market where skincare ranges are introduced without any preservatives and fragrances. Additionally, companies are using a limited number of chemical ingredients and offering D.E.F.I packaging i.e. Device for Exclusive Formula Integrity (D.E.F.I) packaging which helps to protect the formula from oxidation. Dermatological product providers are working in tandem with dermatologists to develop skin formulations and are also attaching dermatologists’ recommended claims, to gain consumer loyalty. Advanced technologies are gaining admiration in dermatological products. Manufacturers are concentrating on introducing new delivery systems and introducing less invasive devices for customers. Many advanced products analyze skin condition with the aid of sensors and then recommends skin improvement with the help of skin therapy. Development in nanomedicines, modification in Nanocarriers, and use of antioxidants finds large application in the cosmetics industry and skincare products. For instance, nanoparticles are widely used in UV-light absorbing sunscreen and anti-aging products. Thus, the development of new technologies in dermatological products surges market growth.

Dermatologicals Market Challenges

The Rising Side Effects of Dermatological Products are impeding the market growth.

Dermatological products cause various side effects such as skin irritation, itches, and many more. According to the World Health Organization, about 200 million people are suffering from rashes owing to the excessive use of dermatology products which further restrains the market growth. Dermatology providers need to counsel patients that topical steroids are extremely safe when used as directed. But cutaneous side effects can happen if patients or providers use topical steroids for too long, at too high a potency, or on an area of the body for which they’re not prescribed. Skin problems that can occur include skin atrophy, irreversible striae, telangiectasias, purpura, hyper- or hypo-pigmentation, acne-like perioral or periorbital dermatitis, as well as cataracts and increased intraocular pressure when applied periorbitally. According to the Department of Dermatology, it is commonly reported that medicines have side effects related to dermatological practice. However, it is extremely difficult to establish how commonly, or rarely skin-related medication side effects occur. Common dermatological side effects include rash, pruritus, and photosensitivity.

Dermatologicals Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Dermatologicals Market. The top 10- Dermatologicals Market companies are-

  1. Sol-Gel Technologies
  2.  Sun Pharma
  3. Bayer AG
  4. Johnson & Johnson
  5. Pfizer Inc.
  6. Novartis AG
  7. GlaxoSmithKline plc
  8. AstraZeneca
  9. Galderma S.A.
  10. Merck KGaA

Recent Developments

  •  In November 2021, Sun Pharma launched Winlevi Cream which is used for the treatment of acne vulgaris in patients 12 years and older, in the U.S. market. 
  • In July 2021, Sol-gel Technologies announced that the Food and Drug Administration (FDA) has approved its first proprietary drug product, TWYNEO (tretinoin/benzoyl peroxide) cream, 0.1%/3%, indicated for the treatment of acne vulgaris in adults and pediatric patients nine years of age and older.
  • In July 2020, Sol-Gel Technologies partnered with generic drug manufacturers in order to develop and commercialize branded and generic topical drug products for the treatment of skin diseases.

Relevant Titles

Report Code- HCR 0108

Report Code- HCR 1307

Report Code-HCR 1479

For more Lifesciences and Healthcare related reports, please click here

1. Dermatologicals Market - Overview
    1.1 Definitions and Scope
2. Dermatologicals Market - Executive Summary
3. Dermatologicals Market –Comparative Analysis
    3.1 Company Benchmarking – Key Companies
    3.2 Financials Analysis - Key Companies
    3.3 Market Share Analysis- Key Companies
    3.4 Patent Analysis - Global
    3.5 Pricing Analysis- Average Price
4. Dermatologicals Market - Startup companies Scenario Premium Premium 
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. Dermatologicals Market – Industry Market Entry Scenario Premium Premium 
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Dermatologicals Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power Of Suppliers
        6.3.2 Bargaining Powers Of Customers
        6.3.3 Threat Of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat Of Substitutes
7. Dermatologicals Market -Strategic analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Dermatologicals Market – By Diseases
    8.1 Acne
    8.2 Dermatitis
    8.3 Psoriasis
    8.4 Skin Cancer
    8.5 Rosacea
    8.6 Alopecia
    8.7 Others
9. Dermatologicals Market – By Route of Administration
    9.1 Topical Administration
    9.2 Oral Administration
    9.3 Parenteral Administration
10. Dermatologicals Market - By Geography
    10.1 North America
        10.1.1 U.S.
        10.1.2 Canada
        10.1.3 Mexico
    10.2 Europe
        10.2.1 U.K.
        10.2.2 Germany
        10.2.3 France
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Russia
        10.2.7 Rest of Europe
    10.3 Asia-Pacific
        10.3.1 China
        10.3.2 Japan
        10.3.3 South Korea
        10.3.4 India
        10.3.5 Australia & New Zealand
        10.3.6 Rest of APAC
    10.4 South America
        10.4.1 Brazil
        10.4.2 Argentina
        10.4.3 Chile
        10.4.4 Colombia
        10.4.5 Rest of South America
    10.5 Rest of the World
        10.5.1 Middle East
        10.5.2 Africa
11. Dermatologicals Market - Entropy
12. Dermatologicals Market – Industry/Segment Competition Landscape Premium 
    12.1 Market Share Analysis
        12.1.1 Market Share by Region – Key companies
        12.1.2 Market Share by Country- Key companies
    12.2 Competition Matrix
    12.3 Best Practices for Companies
13. Dermatologicals Market – Key Company List by Country Premium Premium
14. Dermatologicals Market Company Analysis (Company Revenue, Services, M&A, Developments)
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10 
"*Financials for private companies would be provided on a best efforts basis”.